newsfilter
← Latest News
Business Wire·

Imvax Further Strengthens Leadership Team with Appointment of Josh Muntner as Chief Financial Officer

Imvax, a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies, announced the appointment of Josh Muntner as the company's chief financial officer effective August 31, 2021. "We are proud to further bolster